TGA Updates Compliance Principles for 2026–2027

TGA Updates Compliance Principles for 2026–2027

22 Jan 2026

The new framework covers all TGA-regulated products, including medicines, medical devices, complementary medicines, and unapproved goods. It aims to protect public health while supporting voluntary compliance and improving responses to emerging risks.

The five compliance principles are: safeguard products, educate and inform, protect vulnerable populations, leverage digital tools, and enforce regulations proportionately.

Priority focus areas include direct-to-consumer diagnostic kits, vaping products, medicinal cannabis, listed medicine advertising, substandard or counterfeit products, and therapeutic goods used in cosmetic procedures.

Compliance issues can be reported via the TGA website.

https://www.tga.gov.au/

Source: Therapeutic Goods Administration